HRTX
Heron Therapeutics Inc.
$1.30
+$0.07(+5.69%)
33
Overall
--
Value
33
Tech
--
Quality
Market Cap
$190.08M
Volume
1.50M
52W Range
$1.04 - $2.68
Target Price
$4.75
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | -- | $1.3M | $30.8M | -- | $146.0M | $88.6M | $86.3M | $107.7M | $127.0M | $144.3M | ||
| Total Revenue | -- | $1.3M | $30.8M | -- | $146.0M | $88.6M | $86.3M | $107.7M | $127.0M | $144.3M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | -- | $-35.0K | $-4.6M | $27.5M | $61.6M | $36.2M | $46.0M | $54.9M | $65.1M | $38.6M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | -- | $1.2M | $-4.6M | $-27.5M | $84.4M | $52.4M | $40.3M | $52.8M | $61.9M | $105.6M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-96.9M | $-172.2M | $-225.3M | $233.9M | $295.0M | $280.6M | $258.2M | $227.5M | $172.6M | $117.2M | ||
| Research & Development | $61.2M | $103.1M | $138.6M | $140.0M | $167.4M | $174.5M | $130.8M | $107.5M | $39.1M | $16.7M | ||
| Research Expense | $61.2M | $103.1M | $138.6M | $140.0M | $167.4M | $174.5M | $130.8M | $107.5M | $39.1M | $16.7M | ||
| Selling, General & Administrative | $35.7M | $69.0M | $82.2M | $93.9M | $127.7M | $106.1M | $127.3M | $120.0M | $133.4M | $100.5M | ||
| Selling & Marketing Expenses | $17.3M | $47.7M | $56.6M | $64.6M | $89.8M | $63.9M | $87.2M | $82.5M | $67.6M | $47.1M | ||
| General & Administrative Expenses | $18.4M | $21.4M | $25.6M | $29.3M | $37.9M | $42.2M | $40.2M | $37.4M | $65.8M | $53.4M | ||
| Salaries & Wages | $-14.4M | $-26.0M | $-30.5M | $-33.4M | -- | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-700.0K | $-1.1M | $-1.5M | $-1.5M | $2.0M | $2.8M | $3.0M | $2.9M | $2.9M | $2.5M | ||
| Depreciation & Amortization | $-700.0K | $-1.1M | $-1.5M | $-1.5M | $2.0M | $2.8M | $3.0M | -- | -- | -- | ||
| Amortization | $-624.0K | $-689.0K | $-773.0K | $-890.0K | $1.1M | $1.4M | $785.0K | $202.0K | $206.0K | $751.0K | ||
| Other Operating Expenses | -- | -- | -- | $-2.3M | $-2.3M | $-2.3M | $-2.1M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-96.9M | $-170.9M | $-225.3M | $-261.4M | $-210.7M | $-228.2M | $-217.8M | $-174.7M | $-110.6M | $-11.5M | ||
| EBITDA | $-95.5M | $-168.8M | $-194.3M | $-178.4M | $-203.9M | $-222.5M | $-215.3M | $-190.3M | $-104.9M | $-2.6M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $958.0K | $2.7M | $3.9M | $2.7M | $1.5M | $1.9M | $2.4M | $2.5M | $3.9M | $6.0M | ||
| Intinc | $65.0K | $445.0K | $1.0M | $6.0M | $7.3M | $3.6M | $433.0K | $1.6M | $3.4M | $3.5M | ||
| Net Non-Operating Interest Income/Expense | $-958.0K | $-2.2M | $-2.9M | $3.3M | $5.8M | $1.7M | $-2.0M | $-836.0K | $-504.0K | $-2.5M | ||
| Gain on Sale of Securities | $40.0K | $23.0K | $7.0K | $77.0K | $8.0K | -- | -- | -- | -- | -- | ||
| Other Income/Expense | $-292.0K | $9.0K | $-30.7M | $-79.3M | $-158.0K | $847.0K | $878.0K | $-6.5M | $-560.0K | $-430.0K | ||
| Other Special Charges | $292.0K | $-9.0K | $30.7M | $79.3M | $158.0K | $-847.0K | $-878.0K | $-6.5M | $560.0K | $430.0K | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | $5.6M | -- | -- | -- | -- | ||
| Special Income Charges | -- | -- | -- | -- | -- | $-5.6M | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-96.9M | $-170.9M | $-196.3M | $-177.4M | $-203.2M | $-225.4M | $-218.3M | $-193.4M | $-108.2M | $-6.0M | ||
| Pre-Tax Income | $-97.6M | $-173.1M | $-197.5M | $-178.8M | $-204.7M | $-227.3M | $-220.7M | $-182.0M | $-110.6M | $-13.6M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-352.0K | $-2.0M | $-74.4M | -- | $-9.8M | $-8.2M | $-8.7M | $-13.9M | $-1.5M | $1.5M | ||
| NET INCOME | ||||||||||||
| Net Income | $-97.6M | $-173.1M | $-197.5M | $-178.8M | $-204.7M | $-227.3M | $-220.7M | $-182.0M | $-110.6M | $-13.6M | ||
| Net Income (Continuing Operations) | $-97.6M | $-173.1M | $-197.5M | $-178.8M | $-204.7M | $-227.3M | $-220.7M | $-182.0M | $-110.6M | $-13.6M | ||
| Net Income (Discontinued Operations) | $-97.6M | $-173.1M | $-197.5M | $-178.8M | $-204.7M | $-227.3M | $-220.7M | $-182.0M | $-110.6M | $-13.6M | ||
| Net Income (Common Stockholders) | $-97.6M | $-173.1M | $-197.5M | $-178.8M | $-204.7M | $-227.3M | $-220.7M | $-182.0M | $-110.6M | $-13.6M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-229.4M | -- | -- | -- | ||
| TOTALS | ||||||||||||
| Total Expenses | $-96.9M | $-172.2M | $-229.9M | $261.4M | $356.7M | $316.8M | $304.2M | $282.3M | $237.7M | $155.8M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $33.1M | $37.9M | $54.0M | $73.2M | $81.8M | $90.8M | $98.5M | $108.9K | $138.1M | $152.4M | ||
| Average Shares Outstanding (Diluted) | $33.1M | $38.0M | $54.1M | $73.2M | $81.8M | $90.8M | $98.5M | $108.9K | $138.1M | $152.4M | ||
| Shares Outstanding | $36.2M | $53.6M | $64.6M | $78.2M | $90.4M | $91.4M | $102.1M | $119.3M | $153.3M | $152.3M | ||
| Basic EPS | -- | -- | -- | -- | $-2.5 | $-2.5 | $-2.24 | $-1.67 | $-0.80 | $-0.09 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $-2.5 | $-2.5 | $-2.24 | $-1.67 | $-0.80 | $-0.09 | ||
| Diluted EPS | $-2.95 | $-4.56 | $-3.65 | $-2.44 | $-2.5 | $-2.5 | $-2.24 | $-1.67 | $-0.80 | $-0.09 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $-2.44 | -- | -- | -- | $-1.67 | $-0.80 | $-0.09 | ||
| OTHER METRICS | ||||||||||||
| Gain On Sale Of P P E | $118.0K | $-9.0K | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Interest Expense Operating | $-300.0K | $-400.0K | $-2.8M | $-1.2M | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $18.4M | $21.4M | $25.6M | $29.3M | $37.9M | $42.2M | $40.2M | $37.4M | $65.8M | $53.4M | ||
| Rent And Landing Fees | $18.4M | $21.4M | $25.6M | $-3.2M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $17.3M | $47.7M | $56.6M | $64.6M | -- | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | -- | $5.6M | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HRTX | $1.30 | +5.7% | 1.50M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |